ARTICLE | Distillery Therapeutics
Neurology; autoimmune disease
July 24, 2018 4:11 PM UTC
Patient sample, in vitro, cell culture and mouse studies identified a peptide-based inhibitor of the MYD88-TLR2 interaction that could help treat AD, MS, and RA. In postmortem prefrontal cortical tiss...
BCIQ Company Profiles